OT
Osteal Therapeutics, Inc.
SEC filingPharmaceuticals · Dallas, TX
Amount raised$15.6Msold at filing
Total offering$26.7M$11.1M still open
Investors in the raise10count reported to the SEC
FiledNov 5, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Martin SandsDirector
Judson CooperDirector
Brian de BeaubienExecutive Officer, Director
David ThompsonExecutive Officer, Director
Biren MehtaDirector
Douglas KohrsDirector
David CashDirector
Rushu LuoDirector
Erik OrosDirector
Sonal PatelDirector
Executive officers, directors and promoters as listed on the Form D.